11-34882782-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate
The NM_015957.4(APIP):c.664G>A(p.Val222Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000392 in 1,608,494 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_015957.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
APIP | NM_015957.4 | c.664G>A | p.Val222Ile | missense_variant | 7/7 | ENST00000395787.4 | |
APIP | XM_011520154.4 | c.715G>A | p.Val239Ile | missense_variant | 8/8 | ||
APIP | XM_017017875.3 | c.448G>A | p.Val150Ile | missense_variant | 8/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
APIP | ENST00000395787.4 | c.664G>A | p.Val222Ile | missense_variant | 7/7 | 1 | NM_015957.4 | P1 | |
APIP | ENST00000532428.6 | c.523G>A | p.Val175Ile | missense_variant, NMD_transcript_variant | 5/8 | 1 | |||
APIP | ENST00000527830.1 | n.630G>A | non_coding_transcript_exon_variant | 6/6 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152100Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.0000882 AC: 22AN: 249536Hom.: 0 AF XY: 0.0000963 AC XY: 13AN XY: 134980
GnomAD4 exome AF: 0.0000378 AC: 55AN: 1456394Hom.: 0 Cov.: 27 AF XY: 0.0000455 AC XY: 33AN XY: 724678
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152100Hom.: 1 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74296
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 10, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at